# NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

> **NCT01694576** · PHASE2 · TERMINATED · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 10 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Adjuvant chemotherapy with paclitaxel and nedaplatin

## Key facts

- **NCT ID:** NCT01694576
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** slow patient enrollment
- **Last updated:** 2015-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694576, "NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01694576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
